CN103301305A - Traditional Chinese medicine for treating prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN103301305A CN103301305A CN2013101924089A CN201310192408A CN103301305A CN 103301305 A CN103301305 A CN 103301305A CN 2013101924089 A CN2013101924089 A CN 2013101924089A CN 201310192408 A CN201310192408 A CN 201310192408A CN 103301305 A CN103301305 A CN 103301305A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- traditional chinese
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating prostatic hyperplasia. The traditional Chinese medicine is prepared from the following raw materials by weight: rhizoma dioscoreae colletii, calamus, raw liquorice, poria cocos, radix bupleuri, root of common peony, the root of red-rooted salvia, angelica sinensis, medicinal cyathula root, raw oyster shell, bulbus fritillariae cirrhosae, radix scrophulariae, selfheal, bryozoatum, seaweed and kelp; all the raw materials are added with 1000 ml of water and decocted to 200 ml for the first time, and then added with 700 ml of water and decocted to 200 ml for the second time; the decoction is taken twice each day in the morning and the evening before eating.
Description
Technical field:
The present invention relates to a kind of Chinese medicine, particularly relate to a kind of Chinese medicine that is used for the treatment of prostate hyperplasia.
Background technology:
Prostate hyperplasia (that is prostatic hyperplasia) is middle-aging male commonly encountered diseases and frequently-occurring disease, main clinical manifestation is frequent micturition, nocturia increased frequency, the wait of urinating, the urine line is thin, the urine line is interrupted or not to the utmost dripping, and increase the weight of gradually, overflow incontinence, acute urinary retention etc. can appear in severe patient; The sick category of " difficulty in urination " " gonorrhea " that belongs to Chinese medicine.At present, the therapeutic modality of prostate hyperplasia has Drug therapy, operative treatment and minimally-invasive treatment etc., although operation is treatment means the most thoroughly, for slight hypertrophy and older and can not tolerate surgery person, Drug therapy remains the important method of at first selecting; And the Chinese traditional treatment prostate hyperplasia has history in several thousand, and aspect the treatment prostate hyperplasia, Chinese medicine has its unique advantage, by the integral body conditioning, allows self be balanced, and urinary function strengthens.
Treat clinically prostate hyperplasia comparatively thorny, general treatment oral western medicine or Chinese patent medicine, severe patient uses catheter, cures the symptoms, not the disease, and does not reach the purpose for the treatment of.
Summary of the invention:
The present invention is a kind of instant effect, good effect, Chinese medicine preparation without any side effects.
Medicine of the present invention is that the Chinese medicine by following weight is that raw material is prepared from:
CAOXIE 15g Rhizoma Acori Graminei 10g Radix Glycyrrhizae 10g Poria 10g Radix Bupleuri 10g Radix Paeoniae Rubra 15g Radix Salviae Miltiorrhizae 15g Radix Angelicae Sinensis 15g Radix Cyathulae 10g
Concha Ostreae 30g Bulbus Fritillariae Cirrhosae 10g Radix Scrophulariae 15g Spica Prunellae 15g Pumex 15g Sargassum 15g Thallus Laminariae (Thallus Eckloniae) 15g
Said medicine can be made the dosage form any for oral administration on the pharmaceutics, the preferred dosage form of the present invention is decoction.
The concrete preparation method of medicine of the present invention is first dose of said medicine to be added 1000 milliliters in water fry in shallow oil to 200 milliliters, and second dose adds 700 milliliters in water and fry in shallow oil to 200 milliliters.
Using method is the decoction oral that will fry in shallow oil, every day twice, sooner or later empty clothes.
The traditional Chinese medical science is thought prostate hyperplasia, and pathogenesis is take damp invasion of lower energizer, qi depression to blood stasis as main, and the soothing liver-QI eliminating stagnation is auxiliary.The described prostatic of modern medicine just is being the running course of channel area-covered of traditional Chinese medical science liver meridian, because of the continuous hypertrophy of prostata tissue, and the caused difficulty in urination symptom of compressing urethra, namely Liver Channel smoulders, so reply Liver Channel knot is swollen, unclogs and readjusts dissipation.Rhizoma Dioscoreae Septemlobae, Rhizoma Acori Graminei, Poria divide Qinghua turbid in the side, relieving stranguria by diuresis; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae nourshing blood and promoting blood circulation, dredging the meridian; The Radix Bupleuri soothing liver-QI for relieving depression, bar reaches mechanism of qi, and priming enters liver and passages through which vital energy circulates thereof; Concha Ostreae, Pumex, Sargassum, Thallus Laminariae (Thallus Eckloniae), Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, Spica Prunellae softening the hard mass removing food stagnancy are eliminated the pent-up lump; The Radix Cyathulae priming is descending, through sick institute.Therefore take this side, Liver Channel smoulders to such an extent that disappear, the passages through which vital energy circulates dredging, and urinary tract is unobstructed, thereby reaches the purpose for the treatment of.
Curative effect of medication of the present invention is good, instant effect, taking convenience, have no side effect, and prostate hyperplasia is had good therapeutic effect
Be further clinical efficacy and the safety of proof medicine of the present invention.Select 69 routine patients that medicine of the present invention is carried out clinical observation.
Among the 69 routine patients, following person's 20 examples of 50 one full year of life, 50-60 one full year of life person 21 examples, above person's 28 examples of 60 one full year of life.All use the present invention to treat, every day potion, every day twice, sooner or later empty clothes.
Criterion of therapeutical effect: produce effects: the prostate hyperplasia symptom disappears, and urinary tract is unobstructed; Effectively: the prostate hyperplasia symptom alleviates, and urinary tract is logical; Invalid: the treatment front and back are without significant change.
Curative effect statistical result after table 1 treatment
| The patient | The example number | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| Following person of 50 one full year of life | 20 | 18(90) | 2(10) | 0(0) | 20(100) |
| 50-60 person between one full year of life | 21 | 15(71.4) | 5(23.8) | 1(4.8) | 20(95.2) |
| Above person of 60 one full year of life | 28 | 12(42.3) | 14(50) | 2(7.7) | 26(92.3) |
| Amount to | 69 | 45(65.2) | 21(30.4) | 3(4.4) | 66(95.6) |
The specific embodiment:
Rhizoma Dioscoreae Septemlobae 15g Rhizoma Acori Graminei 10g Radix Glycyrrhizae 10g Poria 10g Radix Bupleuri 10g Radix Paeoniae Rubra 15g Radix Salviae Miltiorrhizae 15g Radix Angelicae Sinensis 15g Radix Cyathulae 10g
Concha Ostreae 30g Bulbus Fritillariae Cirrhosae 10g Radix Scrophulariae 15g Spica Prunellae 15g Pumex 15g Sargassum 15g Thallus Laminariae (Thallus Eckloniae) 15g
Fry in shallow oil into decoction after will said medicine mixing, first dose adds 1000 milliliters in water and fries in shallow oil to 200 milliliters, and second dose adds 700 milliliters in water and fry in shallow oil to 200 milliliters every day twice, sooner or later empty clothes.
Claims (2)
1. Chinese medicine that is used for the treatment of prostate hyperplasia is to be made by the medicine of following weight:
Rhizoma Dioscoreae Septemlobae 15g Rhizoma Acori Graminei 10g Radix Glycyrrhizae 10g Poria 10g Radix Bupleuri 10g Radix Paeoniae Rubra 15g Radix Salviae Miltiorrhizae 15g Radix Angelicae Sinensis 15g Radix Cyathulae 10g.
Concha Ostreae 30g Bulbus Fritillariae Cirrhosae 10g Radix Scrophulariae 15g Spica Prunellae 15g Pumex 15g Sargassum 15g Thallus Laminariae (Thallus Eckloniae) 15g
2. described a kind of Chinese medicine that is used for the treatment of prostate hyperplasia according to claim 1 is characterized in that described medicine with being decocted in water for oral dose into decoction oral.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101924089A CN103301305A (en) | 2013-05-11 | 2013-05-11 | Traditional Chinese medicine for treating prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101924089A CN103301305A (en) | 2013-05-11 | 2013-05-11 | Traditional Chinese medicine for treating prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103301305A true CN103301305A (en) | 2013-09-18 |
Family
ID=49127311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101924089A Pending CN103301305A (en) | 2013-05-11 | 2013-05-11 | Traditional Chinese medicine for treating prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301305A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816363A (en) * | 2014-03-14 | 2014-05-28 | 庄妍 | Chinese herbal preparation for treating senile benign prostatic hyperplasia |
| CN104491312A (en) * | 2014-12-22 | 2015-04-08 | 广东聚智诚科技有限公司 | Use of tradtional Chinese medicine preparation in preparing medicines for treating prostatitis and prostatauxe |
| CN104524106A (en) * | 2014-12-22 | 2015-04-22 | 广东聚智诚科技有限公司 | Traditional Chinese medicine preparation for treating prostatitis and prostatic hyperplasia and preparation method thereof |
-
2013
- 2013-05-11 CN CN2013101924089A patent/CN103301305A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 飞华健康网医生组: "《飞华健康网》", 2 November 2012, HTTP://M.FH21.COM.CN/ZZK/ARTICLE/DETAIL/93581.HTML * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816363A (en) * | 2014-03-14 | 2014-05-28 | 庄妍 | Chinese herbal preparation for treating senile benign prostatic hyperplasia |
| CN104491312A (en) * | 2014-12-22 | 2015-04-08 | 广东聚智诚科技有限公司 | Use of tradtional Chinese medicine preparation in preparing medicines for treating prostatitis and prostatauxe |
| CN104524106A (en) * | 2014-12-22 | 2015-04-22 | 广东聚智诚科技有限公司 | Traditional Chinese medicine preparation for treating prostatitis and prostatic hyperplasia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526634B (en) | Traditional Chinese medicine preparation for curing hyperplasia of mammary glands | |
| CN104162124A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN102114230B (en) | Medicament for treating psoriasis | |
| CN103301305A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
| CN102698024B (en) | Oral traditional Chinese medicine preparation for treating postoperative intestinal adhesion | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN101007159A (en) | Traditional Chinese medicine for preventing and controlling tumor | |
| CN102698130B (en) | Traditional Chinese medicine extract for treating postoperative intestinal adhesion | |
| CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN104189273A (en) | Traditional Chinese medicine used for treating thrombophlebitis | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103893621A (en) | Traditional Chinese medicament for treating senile vaginitis | |
| CN103784663A (en) | Traditional Chinese medicine for treating tubal obstruction | |
| CN104161861A (en) | Traditional Chinese medicine for treating senile constipation | |
| CN104258279A (en) | Traditional Chinese medicine for treating irregular menstrual period | |
| CN104367862A (en) | Traditional Chinese medicinal composition for treating urethral calculus | |
| CN104027515A (en) | Traditional Chinese medicine used for treating intestinal obstruction | |
| CN103301399A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN104042728A (en) | Traditional Chinese medicine for treating rectocele | |
| CN102727594B (en) | Preparation method for Chinese herbal lotion used for treating kidney-yang deficiency type trichomonas vaginitis | |
| CN103877277A (en) | Traditional Chinese medicine for treating impotence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130918 |
|
| RJ01 | Rejection of invention patent application after publication |